ClinicalTrials.gov
ClinicalTrials.gov Menu

The Effectiveness of Skill-Based HIV Psychoeducation in IV-Drug Abuser for Reducing High-risk Behavior

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00935103
Recruitment Status : Completed
First Posted : July 8, 2009
Last Update Posted : August 26, 2015
Sponsor:
Information provided by (Responsible Party):
Iran University of Medical Sciences

Study Description
Go to 
Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
The Effectiveness of Skill-Based HIV Psychoeducation in IV-Drug abuser for reducing high-risk behavior

Condition or disease Intervention/treatment Phase
Addiction Risk Reduction Behaviour Behavioral: Psychoeducation Phase 1 Phase 2

Study Design
Go to 
Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 120 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Participant)
Primary Purpose: Health Services Research
Official Title: The Effectiveness of Skill-Based HIV Psychoeducation in IV-Drug Abuser for Reducing High-risk Behavior
Study Start Date : March 2009
Actual Primary Completion Date : March 2011
Actual Study Completion Date : March 2011

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Drug Abuse HIV/AIDS
U.S. FDA Resources

Arms and Interventions
Go to 
Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Arm Intervention/treatment
Active Comparator: Psychoeducation
Psycheducation
 Behavioral: Psychoeducation
No Intervention: Control


Outcome Measures
Go to 
Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. decrease of IV usage of opioid increase usage of condom and safety syringe [ Time Frame: 12 months ]

Eligibility Criteria
Go to 
Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

Age more than 18 years old Dependency to opioid drugs (Positive result of Urin addiction test)

Exclusion Criteria:

suicide attempt not tendency for including to the study receiving treatment for addiction in recent months.

Contacts and Locations
Go to 
Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

No Contacts or Locations Provided
More Information
Go to 
Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Responsible Party: Iran University of Medical Sciences
ClinicalTrials.gov Identifier: NCT00935103     History of Changes
Other Study ID Numbers: 117
First Posted: July 8, 2009    Key Record Dates
Last Update Posted: August 26, 2015
Last Verified: July 2009

Keywords provided by Iran University of Medical Sciences:
Addiction
Psychoeducation
Risk reduction behaviour
Drop in center (DIC)

Additional relevant MeSH terms:
Behavior, Addictive
Compulsive Behavior
Impulsive Behavior